Semprex-D

Active Ingredient(s): Acrivastine + Pseudoephedrine
FDA Approved: * March 25, 1994
Pharm Company: * UCB INC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Semprex-D Overview

Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine (like its base molecule triprolidine) and works by blocking histamine H1 receptors. This non-sedating[verification needed] antihistamine is sold under the brand name Benadryl Allergy Relief in the United Kingdom by McNeil Laboratories. It should not be confused with Benadryl Once a Day which has cetirizine as the active ingredient and is...

Read more Semprex-D Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Acrivastine

Recent Semprex-D Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Acrivastine + Pseudoephedrine
  • Capsule: 8mg + 60mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Semprex-D: (1 result)

Sorted by National Drug Code
  • 53014-404 Semprex-d (Acrivastine 8 mg / Pseudoephedrine Hydrochloride 60 mg) Oral Capsule by Ucb, Inc.

Drugs with one or more similar ingredients: (326 results)

Related Semprex-D Topics:

semprex-D
decongestant...
medeva semprex-d
white and green capsule...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 3 March 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA